Background
1. Field of the Invention
The present invention relates to systems and methods for cardiopulmonary bypass, and in particular the present invention relates to a novel system and method of mechanical heart-lung substitution which is fully portable and semi-automatic and which is particularly adapted for utilization outside the hospital environment as an emergency life-support system for sustaining the life of a patient suffering from acute, severe, lift-threatening cardiac and/or respiratory failure.
2. The Prior Art
When acute, severe, life-threatening but potentially reversible interruption of natural cardiac and/or pulmonary function occurs, emergency application of effective methods for maintaining at least partial cardiopulmonary function until the primary threat to life can be corrected may permit all vital organs and/or systems to resume normal self-regulating function, thereby averting death. In actual clinical practice, such life-support efforts currently take one of three forms: (1) emergency cardiopulmonary resuscitation (CPR); (2) temporary mechanical cardiopulmonary bypass (CPB) for support of patients undergoing open heart surgery; and (3) modified partial cardiopulmonary bypass, which is also called extracorporeal membrane oxygenation (ECMO), which is used for mechanical assistance of patients in acute, severe but reversible pulmonary failure.
CPR is used each day to save literally several hundred persons who collapse unexpectedly at home, at work, in the field, or in hospitals, and is an accepted technique for providing temporary cardiopulmonary assistance in emergency situations. However, there is no question that cardiopulmonary bypass machines or extracorporeal membrane oxygenation systems are much more effective in maintaining proper hemodynamic function and blood gas exchanges than is cardiopulmonary resuscitation. In proper hospital environments, cardiopulmonary bypass and/or extracorporeal membrane oxygenation can be carried out longer and with much higher survival rates than can be achieved with cardiopulmonary resuscitation.
Unfortunately, notwithstanding the substantial advantages that can be derived from using cardiopulmonary bypass and/or extracorporeal membrane oxygenation systems, such systems are not currently available outside the operating room or hospital environment, and they require considerable preparation time before they can be applied. For example, typical cardiopulmonary bypass machines are relatively large in size and are highly complicated, usually requiring the use of skilled perfusionists in order to run them. Patients who undergo cardiopulmonary bypass also require major thoracic surgery and therefore the presence of a skilled surgeon is needed in typical situations. Moreover, proper management of the usual cardiopulmonary bypass machine requires the use of highly technical invasive monitoring systems to monitor and record the vital signs of the patient. Thus, for obvious reasons, these types of cardiopulmonary bypass and/or extracorporeal membrane oxygenation systems are not available or practical for use outside the setting of a rather sophisticated hospital facility.
It would be a substantial advance in the state of the art to provide a fully portable mechanical heart-lung substitution system which could be used without the need for major surgical operation and which would be semi-automatic so as to simplify the ease of using and the reliability of such a system. Such an invention would have an important impact on the ability of paramedics or other emergency personnel to provide adequate, temporary cardiopulmonary life support while transporting a patient to a fully equipped hospital facility for longer term or more definitive care. Such an invention is disclosed and claimed herein.
Brief Summary and Objects of the Invention
The present invention comprises a fully portable, semi-automatic mechanical heart-lung substitution system and method. In one presently preferred embodiment of the invention, the system includes a venous cannula that is adapted for insertion under local anaesthetic through the vena caval system of the patient beginning at the right internal jugular vein and continuing to a point inside the right ventricle of the heart. The venous cannula is attached to a roller pump which is used to pump blood from the patient's right heart to a membrane oxygenator connected at the output of the roller pump. The speed of the roller pump is automatically controlled by means of a pressure sensor that is attached to the outer wall of the venous cannula so as to sense the internal venous blood pressure inside the patient's vena cava.
From the oxygenator, the blood flows to a compliance reservoir which expands so as to created increasing pressure as the volume of the blood filling the reservoir increases. The compliance reservoir is connected to a pulsatile left heart pump, and the stroke volume of the left heart pump is automatically controlled by the pressure developed in the compliance reservoir. Blood is output by the pulsatile left heart pump through a filter and bubble trap and then is returned to the patient's arterial system through an arterial cannula that is inserted under local anaesthetic into the right and/or left common carotid artery. The entire system is mounted on a small carrying case which can be transported by hand by emergency personnel.
It is therefore a primary object of the present invention to provide a fully portable semi-automatic mechanical heart-lung substitution system and method which can be employed by emergency personnel in the field for purposes of providing life sustaining cardiopulmonary function in a safe and reliable manner.
Another important object of the present invention is to provide a portable self-contained mechanical heart-lung substitution system which can be applied and discontinued without general anaesthesia and without major surgery.
Yet another important object of the present invention is to provide a mechanical heart-lung substitution system which minimizes the need for systemic anticoagulation of the patient so as to minimize the potential for hemorrhage in the case of seriously injured patients.
Still another important object of the present invention is to provide a system and method of heart-lung substitution which does not require invasive monitoring.
Another important object of the present invention is to provide a system and method of heart-lung substitution which is semi-automatic so as to provide effective and reliable life support of cardiopulmonary function without the need for constant attendance of skilled perfusionists or other technicians.
Yet another important object of the present invention is to provide a system and method of heart-lung substitution which can be maintained in a fully portable, sterile, primed and ready to apply condition for emergency use and which can be instituted and become operational within a matter of minutes.
These and other objects and features of the present invention will become more fully apparent from the following description and appended claims taken in conjunction with the accompanying drawings.
Brief Description of the Drawings
FIG. 1 is a perspective view which schematically illustrates one presently preferred embodiment of the mechanical heart-lung substitution system of the present invention mounted in a portable carrying case.
FIG. 2 is a perspective illustration showing the underside of the portable carrying case, with a portion broken away to reveal the battery and oxygen tank used in the present invention.
FIG. 3 is a cross-sectional view taken along line 3--3 of FIG. 1 so as to illustrate the compliance reservoir of the present invention in more detail.
FIG. 4 is a schematic flow diagram illustrating the functional components of the system as used according to the method of the present invention.
FIG. 5 is a perspective illustration shown in partial cross-section which schematically illustrates the manner in which the mechanical heart-lung substitution system is connected to the venous and arterial systems of a patient.
Detailed Description of the Presently Preferred Embodiment
Reference is first made to FIG. 1, which schematically illustrates a perspective view of one presently preferred embodiment of the invention. As illustrated in FIG. 1, the heart-lung substitution system generally designated at 10 is mounted within a portable carrying case which comprises a bottom part 12 and a top cover 14. The cover 14 is adapted to be securely connected to the bottom part 12 of the carrying case by means of the latch 16 which snaps over a corresponding hook 18. The bottom part 12 of the carrying case also is provided with a small ridge 22 which runs around the top periphery of the bottom part 12 of the carrying case so that the cover 14 will fit securely onto the bottom part 12. The top cover 14 is also provided with a handle 20 so that the entire system can be hand-carried.
As shown in FIG. 2, the bottom 12 may also be provided with folding legs 21 which may be folded up to fit into channels 23 and 25 formed on the underside of bottom part 12. Thus, the carrying case can be either supported by placing it upon the ground or a table, or by elevating it if need be by unfolding the legs 21. This helps to increase the versatility of the mechanical heart-lung system 10.
With reference again to FIG. 1, the bottom part 12 of the carrying case is also provided with a platform 24 securely mounted inside the bottom part 12 of the carrying case. Mounted on the platform 24 is a right heart pump 26 which is comprised of a conventional roller pump having rollers 28 which pump the blood through tubing 34 as hereinafter more fully described. Tubing 34 runs through the end of the lower part 12 of carrying case and is secured by a fitting 33. Tubing 34 is also joined by another fitting 32 to another length of tubing 30 which, as hereinafter more fully described in connection with FIG. 4, is attached to a venous cannula for insertion into the vena caval system of the patient. Thus, as roller pump 26 is operated, blood is pumped by means of the venous cannula out of the vena caval system of the patient.
At the output of roller pump 26, the venous blood pumped out of the patient flows through a flow meter 36 and a pressure gauge 38 which are in line with tubing 40 attached at the output of pump 26. Flow meter 36 may be used to detect the flow rate of blood being pumped out of the patient and the pressure gauge 38 detects the hydraulic pressure at which the blood is flowing through tubing 40.
The blood next flows into a membrane blood oxygenator 44. Oxygenator 44 is attached through tubing 46 to a pressurized tank 52 (see FIG. 2) of oxygen-enriched gas. As shown in FIG. 2, the tank 52 of oxygen-enriched gas is stored beneath the platform 24. As the blood flows through the oxygenator 44, the blood is oxygenated and carbon dioxide is removed in accordance with well-known membrane gas exchange techniques and the oxygenated blood then flows through the blood outlet tube 54 to a compliant reservoir generally designated at 56. Gases are expelled by oxygenator 44 through a gas outlet 48. As used herein, the term "oxygenation" means blood gas exchange including removal of carbon dioxide as well as adding oxygen to the blood.
With reference to FIG. 3, the compliant reservoir 56 comprises an outer case consisting of a bottom part 51 and a top cover 53 which snaps onto the bottom 51 by means of a small lip 65 provided at the upper edge of bottom 51 and a corresponding groove 69 formed in the edge of cover 53. Cover 53 is provided with a handle 55 accessible by means of an indentation 57 formed around the handle 55 (see also FIG. 1). Inside the reservoir, a compliant sac 59 of blood-compatible polymer receives blood from the tubing 54 connected to oxygenator 44. As blood fills the compliant sac 59, the sac 59 exerts an upward force on plate 67 which is held by a spring mechanism 61 secured between cover 53 and plate 67. In this manner, an increasing volume of blood filling sac 59 will result in increasing fluid pressure within sac 59, which may be used to automatically control stroke volume of the left heart pump 58, as hereinafter more fully explained. Other means may be utilized to provide the compliant reservoir, as for example a compliant sac sealed within an airtight chamber.
Blood is pumped from reservoir 56 through tubing 42 by left heart pump 58. The output of pump 58 is connected through tubing 49 to a blood filter and bubble trap 60. The blood filter and bubble trap 60 removes any accumulated particulate and/or gas microemboli and/or macro collections of air from the blood before it is returned to the patient's arterial system. From the filter and bubble trap 60, the blood is returned through a length of tubing 64 which extends through the end of the lower portion 12 of the carrying case by means of fitting 47 and is attached through a second fitting 66 to an arterial line 68. As hereinafter more fully described, the arterial line 68 is connected to an arterial cannula which may be inserted into the left (or both left and right) carotid artery of the patient for return of the blood to the patient's arterial system.
The venous and arterial lines 30 and 68 may be connected by a recirculation line 76 connected at "T" fittings 81 and 79. A "Y" connector 77 is also connected to venous line 30 and is provided with transfusion ports 70 and 72 which are controlled by two-way stopcocks 71 and 73. Blood, plasma, or other infusion fluids may be suspended from the arm 83 of a telescopically collapsible IV stand 85 and connected to ports 70 and/or 72 if transfusion of blood is needed in cases where the patient has lost large amounts of blood. The "T" fitting 79 on arterial line 68 is provided with a stopcock 75 having a port 87 which may be used for sampling arterial blood, sensing arterial line pressure or administering fluids and/or medications into the patient's arterial system. Recirculation line 76 will be typically clamped closed using clamps 89 during perfusion of the patient. When recirculation line 76 is open and blood lines 30 and 68 are closed, the recirculation line 76 permits the system to run without including the patient in the circuit, as for example when priming the circuit.
With reference to FIG. 2, both the right heart pump 26 and the left heart pump 58 are powered by means of a direct current electrical power supply which may be, for example, battery 27. As more fully explained hereinafter, the speed of the right and left heart pumps 26 and 58 can be controlled manually using instrumentation provided with the portable system. For example, as shown in FIG. 1, knobs 29 and 35 can be used to vary the speed of the right and left heart pumps 26 and 58, respectively. Switches 37 and 39 are used to turn the pumps on and off and small lamps 31 and 33 are used to indicate that the pumps are powered and ready for operation. Gauges 11 and 13 indicate flow rate and pressure detected at flow meter 36 and pressure gauge 38, respectively. If desired, gauges 41 and 43 can also be supplied to indicate the speed at which each pump is operating. However, as more fully explained below the mechanical heart-lung substitution system 10 of this invention is designed so as to be semi-automatic in its operation, thereby eliminating the need for manual control to a large extent.
The method of operation of the system is best shown in FIGS. 4 and 5. Referring first to FIG. 5, the venous cannula 78 is a large-bore thin-walled bi-directional cannula which may be inserted under local anaesthesia through a small right cervical skin incision and through a second incision 80 in the right internal jugular vein of the patient. An arterial bi-directional cannula 106 is similarly inserted under local anaesthesia into the right common carotid artery of the patient utilizing the same skin incision made for the venous cannula insertion. As shown in FIG. 5, the tip 108 of the arterial cannula 106 has bi-directional blood outlets 112 and 114 at opposite ends thereof which permit the blood to be returned in both directions in the right common carotid artery 110. If higher blood flow rates at lower input pressures are desired, the left common carotid artery 100 may be similarly cannulated using a second bi-directional arterial cannula 96 which is essentially identical to arterial cannula 106. Both cannulae may be joined by a "Y" connection 94 which delivers blood to the patient from line 68 of the mechanical heart-lung substitution system. Each bi-directional cannula 78, 106 and 96 is tied off with ligatures 109 to prevent bleeding.
With continued reference to FIG. 5, the venous cannula 78 is inserted through the vena cava 82 of the patient until the perforated tip 84 of the long arm of the cannula extends through the tricuspid valve 86 of the right atrium of heart 116 into the right ventricle 88. As illustrated at 90, a small catheter-tip pressure transducer is attached at the outside wall which defines the lumen of the venous cannula 78. Transducer 90 is located on the outer surface of cannula 78, lying in the superior vena cava approximately 12 centimeters upstream from the perforated tip 84. The pressure transducer 90 is attached by a thin wire 92 running in the wall of cannula 78 along the length of the venous cannula 78 back to the right heart pump 26. Pressure sensor 90 is used to control the rate at which blood is pumped by right heart pump 26 from the patient into the mechanical heat-lung system.
The perfusion of blood from the patient's right heart and vena caval system through the mechanical heart-lung substitution system 10 and back to the patient's arterial system is preferably accomplished at a maximum flow rate which should be as near as possible to the normal systemic blood flow rate for the patient (i.e., approximately 80 milliliters of blood per kilogram body weight per minute).
The operation of the mechanical heart-lung system 10 is semi-automatic in that the output of the right heart pump 26 is automatically controlled, as is the output of left heart pump 58, although one or both pumps can also be manually controlled. Significantly, as hereinafter more fully explained, in the automatic mode the output of left heart pump 58 automatically returns the same volume of blood to the patient and at the same rate as is pumped from the patient's vena cava by right heart pump 26.
A pressure sensor 90 is embedded in the wall of the venous cannula 78 and will sense the venous pressure in the patient's caval system. The pressure is converted by transducer 90 into a corresponding electrical signal which is input to the variable voltage potentiometer circuit 105 (see FIG. 4) that controls the right heart pump 26 so that the speed of the pump will maintain a central venous pressure of approximately 0 to 2 mmHg. When the venous blood pressure in the caval system of the patient's system is higher than 2 mmHg, right heart pump 26 will speed up in proportion to the central venous pressure of the patient, and when the pressure is lower than 0 mmHg the right heart pump 26 will decrease in speed so as to maintain the venous presure within the 0-2 mmHg range. In this manner, the system automatically pumps as much blood as possible from the patient so as to maintain a blood flow rate close to normal without collapsing the patient's vena cava. At any time during perfusion, the system can be switched to a manual mode of operation using the control knobs 29 and/or 35.
With reference to FIG. 4, blood from the right heart pump 26 is oxygenated by oxygenator 44 and then collected in the compliant reservoir 56. Internal hemodynamics of the mechanical heart-lung substitution system are controlled automatically by means of the expansile compliant sac 59 and spring mechanism 61, in combination with the pulse rate of left heart pump 58. As blood fills the compliant sac 59 beyond its original volume, the increasing volume in the sac 59 compresses spring 61 by means of plate 67, thus increasing pressure in the compliant sac 59 commensurate with increasing blood volume within the sac. This pressure becomes the filling pressure into the bladder 103 of pulsatile flow left heart pump 58 during the first half or intake portion of the pumping cycle of pump 58, and the volume of blood expelled from reservoir 56 is proportional to the pressure exerted by spring 61. Pump 58 includes a solenoid-actuated pusher plate 101 which empties the bladder 103 of pump 58 during the second half or pumping stroke of each pumping cycle. The pulse rate of left heart pump 58 can be automatically controlled by an electrocardiogram hook-up to the patient, or manually using control knob 35. Thus, as the blood flow from the patient into the mechanical heart-lung system increases, the volume of blood in the compliant reservoir 56 increases and the stroke volume of the left heart pump 58 automatically increases, resulting in automatic regulation of blood flow into the patient's arterial system such that the volume and rate of blood returned to the patient's arterial system is equal to the volume and rate of blood flowing out of the patient's caval system and right heart.
As previously mentioned, any time during perfusion the manual mode of operation can be selected by using the knobs 29 and 35 to adjust the output of either the right heart pump 26 or left heart pump 58 to accommodate for observed changes in the hemodynamics of the patient. Changes in hemodynamics may be observed using the flow meter gauge 11 and/or pressure gauge 13 (see FIG. 1).
Referring again to FIGS. 1 and 2, if additional perfusion flow rate and/or volume are desired, perfusion of appropriate electrolyte solutions, blood or blood products may be accomplished by using the transfusion ports 70 and 72. Each transfusion port 70 and 72 is controlled by a stopcocks 71 and 73 as mentioned above.
It should of course be appreciated that the system and method as generally described above may be implemented in a variety of ways without departing from the spirit and essential characteristics of the present invention. For example, one presently preferred embodiment of the system and method of the invention may be implemented as follows:
Example 1
The venous return cannula 78 may comprise a wire-reinforced large diameter bi-directional cannula approximately 40 centimeters in length such as that manufactured by USCI, a division of C. R. Bard, Inc. of Billerica, Mass., Model No. 008019. The arterial cannulae 106 and 96 may be of the type generally illustrated and described in U.S. Pat. No. 4,173,981, incorporated herein by reference, slightly modified for purposes of the present invention by reducing the length of the long arm of each cannula to approximately one-third of the length as described in the aforesaid patent. Both the venous and arterial cannulae and their connecting adaptors and tubing are surface treated to make them thrombo-resistant.
The right heart pump 26 may be a conventional roller pump such as a Sarns (TM) pump. The flow meter may be a Gould Statham flow probe sensor Model No. SP 7519-500-604, and the pressure gauge may be a Statham Gould Strain Gauge Model Number PB23-DB. The control circuit 105 may comprise any appropriate commercially available solid state variable voltage potentiometer coupled with a current amplifier. Oxygenator 44 may be a William Harvey Model HF-4000 hollow fiber membrane oxygenator manufactured by Bard Cardiopulmonary Division of C. R. Bard, Inc., Santa Ana, Calif. or a Bentley Model BOS-CM microporous oxyenator manufactured by American Bentley, a subsidiary of American Hospital Supply Corporation of Irvine, Calif. The left heart pump may comprise a modified model MK 22C electromagnetic energy convertor integrated with a model IIIA dual pusher plate sac blood pump manufactured by Novacor Medical Corporation of Palo Alto, Calif. The blood filter and bubble trap may be a model AF-1025 or AF-1040 arterial line filter manufactured by American Bentley, a subsidiary of American Hospital Corporation. Pressure sensor 90 may comprise a Millar model MPC-500 catheter-tip pressure sensor manufactured by Millar, Inc. of Houston, Tex.
The initial volume of the compliant sac 59 may be approximately 400 cc. The gas delivered to the membrane oxygenator 44 may be 100% oxygen or a mixture of 96% oxygen and 4% carbon dioxide. The flow rate of gas into the oxygenator will typically be about one to two times that of the blood flow rate through the oxygenator. The temperature of blood flowing through the oxygenator is not controlled, resulting in mild hypothermia during long perfusions, which is not considered undesirable for the intended application of the system of this invention. Blood tubing and other materials of the system are selected based on thrombogenicity characteristics so as to provide an overall system which can be used without systemic anticoagulation. However, if clotting is a problem in any given component of the presently preferred embodiment, it can be overcome by applying antithrombogenic surface coatings to the components of the system, or by administration of prostacyclin and/or platelet-sparing drugs.
The power supply in the above example may comprise a direct current 10 volt electrical system provided by a rechargeable battery which will supply adequate power for up to 8 hours of operation.
In summary, the system and method of the present invention are intended to provide a substantial advancement in the state of the art of cardiopulmonary bypass techniques in temporary emergency situations. The system and method of the present invention provide a fully portable, self-contained semi-automatic mechanical heart-lung substitution system and method. The system and method permit temporary emergency cardiopulmonary bypass without the use of general anaesthesia and without major surgery, and operation of the system is automatically controlled so that it can be used outside the hospital environment by emergency personnel. The semi-automatic operation permits the system to be used without the need for skilled perfusionists and highly technical invasive monitoring equipment, and yet with effective and reliable results.
The invention may be embodied in other forms without departing from the spirit or essential characteristics of the invention, and the presently preferred embodiment as illustrated and described herein is to be considered in all respects only as illustrative and not restrictive of the scope of the invention as set forth in the claims.